Trademark Overview
On Friday, March 14, 2025, a trademark application was filed for MERILOG with the United States Patent and Trademark Office. The USPTO has given the MERILOG trademark a serial number of 99084375. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, March 14, 2025. This trademark is owned by Sanofi. The MERILOG trademark is filed in the Advertising, Business and Retail Services, Pharmaceutical Products, Education & Entertainment Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing training in the field of diabetes and injecting insulin; Publication of articles and scientific journals; Educational services, namely, developing, arranging, and conducting educational conferences and programs and providing courses of instruction in the field of healthcare and medicine for health care providers, care givers, health care insurers, payers in the healthcare field, patients with diabetes and related diseases and disorders, and patients with autoimmune diseases; Entertainment services, namely, providing podcasts in the field of healthcare and medicine; Educational services, namely, conducting conferences, training, seminars, congresses, presentations, and workshops in the field of healthcare and medicine and distribution of educational materials in connection therewith, all the foregoing distributed across multiple forms of transmission media including online via the internet and via social network platforms
Pharmaceutical preparations for human use; Insulin
Administration of a program for enabling participants to obtain discounts on products and services; Administration of a discount program for enabling participants to obtain discounts on goods and services through use of a discount membership card; Promoting public awareness of medications and treatments for diabetes; Providing business information in the field of patient relationship management services for the purpose of assisting prospective patients regarding the treatment of disease via a web site; Providing business information in the field of business administration of patient reimbursement programs regarding medical treatment payment plan options for patients undergoing treatment of disease
Providing medical information in the field of diabetes; Providing medical information; Medical services; Medical services in the field of diabetes, autoimmune diseases and disorders, and related diseases and disorders, namely, providing medical and psychological support for healthcare professionals, patients with diabetes and related diseases and disorders, and patients with autoimmune diseases and disorders; Providing medical information in the field of prevention and treatment of diabetes, autoimmune diseases and disorders, and diseases and disorders related to diabetes; Providing medical information in the field of diabetes, treatment of the disease, burden of the disease, and pathophysiology of the autoimmune nature of the disease via a website; Providing medical information in the field of diabetes, autoimmune diseases, and related diseases and disorders, and on the prevention and early diagnosis of asymptomatic Type 1 diabetes, to health care providers; Providing medical informat...
